Back to Search Start Over

Blockage of protease-activated receptor 2 exacerbates inflammation in high-fat environment partly through autophagy inhibition.

Authors :
Ji Yun Her
Yunna Lee
Su Jin Kim
Gwangbeom Heo
Jieun Choo
Yuju Kim
Howe, Cody
Sang Hoon Rhee
Hak Sun Yu
Hae Young Chung
Pothoulakis, Charalabos
Im, Eunok
Source :
American Journal of Physiology: Gastrointestinal & Liver Physiology; Jan2021, Vol. 320 Issue 1, pG30-G42, 13p
Publication Year :
2021

Abstract

Protease-activated receptor 2 (PAR2) regulates inflammatory responses and lipid metabolism. However, its precise role in colitis remains unclear. In this study, we aimed to investigate the function of PAR2 in high-fat diet-fed mice with colitis and its potential role in autophagy. PAR2<superscript>+/+</superscript> and PAR2<superscript>-/-</superscript> mice were fed a high-fat diet (HFD) for 7 days before colitis induction with dextran sodium sulfate. Deletion of PAR2 and an HFD significantly exacerbated colitis, as shown by increased mortality, body weight loss, diarrhea or bloody stools, colon length shortening, and mucosal damage. Proinflammatory cytokine levels were elevated in HFDfed PAR2<superscript>-/-</superscript> mice and in cells treated with the PAR2 antagonist GB83, palmitic acid (PA), and a cytokine cocktail (CC). Damaging effects of PAR2 blockage were associated with autophagy regulation by reducing the levels of YAP1, SIRT1, PGC-1a, Atg5, and LC3A/B-I/II. In addition, mitochondrial dysfunction was demonstrated only in cells treated with GB83, PA, and CC. Reduced cell viability and greater induction of apoptosis, as shown by increased levels of cleaved caspase-9, cleaved caspase-3, and cleaved poly(ADP-ribose) polymerase (PARP), were observed in cells treated with GB83, PA, and CC but not in those treated with only PA and CC. Collectively, protective effects of PAR2 were elucidated during inflammation accompanied by a high-fat environment by promoting autophagy and inhibiting apoptosis, suggesting PAR2 as a therapeutic target for inflammatory bowel disease co-occurring with metabolic syndrome. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
01931857
Volume :
320
Issue :
1
Database :
Complementary Index
Journal :
American Journal of Physiology: Gastrointestinal & Liver Physiology
Publication Type :
Academic Journal
Accession number :
148103420
Full Text :
https://doi.org/10.1152/ajpgi.00203.2020